Prior Positive Results Confirmed in MAPS-Sponsored, Philanthropy-Funded Phase 3
January 26, 2023
In monumental psychedelic news, on January 5, we confirmed prior positive results in our philanthropy-funded Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder (PTSD).
MAPS Founder and Executive Director Rick Doblin, Ph.D., had this to say:
“When I first articulated a plan to legitimize a psychedelic-assisted therapy through FDA approval, many people said it was impossible. Thirty-seven years later, we are on the precipice of bringing a novel therapy to the millions of Americans living with PTSD who haven’t found relief through current treatments. The impossible became possible through the bravery of clinical trial participants, the compassion of mental health practitioners, and the generosity of thousands of donors. Today, we can imagine that MDMA-assisted therapy for PTSD may soon be available and accessible to all who could benefit.”
The full data from MAPP2, expected to be published in a peer-reviewed journal later this year, will support MAPS PBC’s new drug application to be filed with the U.S. Food and Drug Administration (FDA).
We are so grateful for your support in making this success possible, and we are eager to share the publication of this historic research with you. Stay tuned to the MAPS Newsletter for future updates on this study!
MAPS Featured in Major Media
Our psychedelic research has received major media coverage in the past month. MAPS Founder and Executive Director Rick Doblin, Ph.D, was featured on Fox Business with Kennedy. Articles featuring MAPS ran in publications including The Intercept, High Times, and Benzinga.
Visit our MAPS in the Media webpage to view all media articles about our work.
New Speakers Announced for Psychedelic Science 2023
More speakers have been confirmed for Psychedelic Science 2023! You can view the full list of speakers on the PS2023 website.
Psychedelic Science 2023 takes place June 19-23, 2023, in Denver, Colorado, and is the largest psychedelic gathering in the world. Sign up for exclusive email updates to receive the latest news, or visit our website to explore the agenda or book a hotel to secure the best rates.
Psychedelic Fundamentals: Give the Gift of Learning
Psychedelic Fundamentals, the introductory course in the MAPS Digital Learning series, will guide you through the basics of psychedelics via a series of short, easy-to-follow lessons. The course takes just a few hours and provides you with an overview of the most interesting and important aspects of psychedelic history, science, clinical research, therapeutic uses, and harm reduction, backed by over 36 years of MAPS history as a leading institution for psychedelic education.
Use code HTCYM for 25% off registration for Psychedelic Fundamentals for yourself or your psychedelically curious friends!
In-depth courses on integration, peer support, and more are available for pre-order now. Order today for $80 in savings on each course…the discount only lasts until the courses are launched!
The Promising Science of Psychedelics CourseProduct on saleAvailable at a future date.
Integrating Psychedelic Experiences CourseProduct on saleAvailable at a future date.
Psychedelic Trip Planning CourseProduct on saleAvailable at a future date.
Psychedelic Peer Support CourseProduct on saleAvailable at a future date.
MAPS, MAPS PBC, and MAPS Europe Are Hiring
View our careers page to apply for one of our many open job positions or refer a friend! All of our organizations — MAPS, MAPS Public Benefit Corporation, and MAPS Europe — are hiring for full-time roles from development to clinical science to regulatory compliance.
Follow MAPS on Facebook, Twitter, Instagram, YouTube, and LinkedIn.
Please forward the MAPS Newsletter to a friend! Remember: you can always read all past Newsletters on our website.
Prior Positive Results Confirmed in Phase 3 Trial of MDMA-Assisted Therapy for PTSD (MAPP2)
MDMA Therapy Training Program Update: January 2023
MAPS in the Media
- Fox Business: The FDA Could Approve MDMA-Assisted Therapy by 2024: Rick Doblin, Ph.D.
- The Intercept: Party Drugs for PTS: Study Moves Therapeutic Use of MDMA Toward Approval
- High Times: House Lawmakers Launch Bipartisan Psychedelics Caucus
- The Dales Report: TDR’s Top 5 Psychedelic Developments For The Week Of November 14
- Shondaland: Is Psychedelic-Aided Therapy a Mental Health Game Changer?
- Drug Discovery and Development: Senators Booker and Paul Aim to Reschedule Psilocybin and MDMA to Foster Research
- SALT NY: Psychedelic Renaissance: Breakthrough Mental Health Treatments
- Benzinga: MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next
- Summit Daily: Yampa Valley Clinics Prepare for Psychedelic Mushroom Mental Health Therapy
Events and Programs
Psychedelic Science 2023, June 19-23, 2023, Denver, Colorado
Fluence Professional Education in Psychedelic-Assisted Psychotherapy and Integration – Ongoing
Polaris Insight Center: Ongoing Training and Retreats
Beckley Academy’s Foundations of Psychedelic-Assisted Therapy, January 26 and February 8, 2023, Online
Integrative Psychiatry Institute Psychedelic-Assisted Therapy Training, July 2022 – May 2023
Convergence, March 30 – April 2, 2023, Los Angeles, California
Reworlding Fellowship Application Now Available
Thank you to Dr. Bronner’s for their support of the MAPS Newsletter!